Skip to content

Savara SVRA Total Revenue

Discontinued — last reported Q3 '21

Total Revenue at other companies

XER
Xeris Biopharma Holdings, Inc.XERS
$83.13M+38.3%
Innoviva, Inc. logo
Innoviva, Inc.INVA
$97.99M+10.6%
Theravance Biopharma logo
Theravance BiopharmaTBPH
$17.7M+15.0%
ANI Pharmaceuticals logo
ANI PharmaceuticalsANIP
$237.46M+20.5%
Eton Pharmaceuticals, Inc. logo
Eton Pharmaceuticals, Inc.ETON
$24.27M+40.4%
Viridian Therapeutics, Inc. logo
Viridian Therapeutics, Inc.VRDN
$141K+95.8%

Other financials

Income statement

See full
Operating income-$39.0M-37.1%
Net income-$37.3M-40.0%
EPS (diluted)-$0.15-25.0%

Balance sheet

See full
Cash & equivalents$38.8M+98.4%
Total debt$30.1M+1.8%
Total equity$176.0M+19.1%
Total assets$221.6M+17.1%

Cash flow

See full
Operating cash flow-$33.0M-21.5%
CapEx$54.0K+1,700%
Free cash flow-$33.1M-21.7%

Valuation

See full
Market cap$1.19B+134%
Enterprise value$1.19B+127%
P/S4,648.7×

Profitability

See full
Operating margin-19,183.3%
Net margin-19,305.1%
FCF margin-15,518.7%

Returns & leverage

See full
Return on equity-80%+4.7pp
Debt / equity0.2×0.0×
Current ratio13.5×-1.4×

Where this comes from

Reported directly by Savara in its filing.

Tagged under the XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax.

The official record: Savara’s 10-Q, filed November 12, 2021, on SEC EDGAR. View the filing →

Ask your AI about Savara's total revenue.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Savara's total revenue?
Savara (SVRA) reported total revenue of $0 in Q3 2021.
What does total revenue mean?
The aggregate of all revenue from the company's operations — the top line from which all profitability metrics are derived.